These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16896537)

  • 21. Dielectrophoretic characterisation of Friend murine erythroleukaemic cells as a measure of induced differentiation.
    Burt JP; Pethig R; Gascoyne PR; Becker FF
    Biochim Biophys Acta; 1990 Apr; 1034(1):93-101. PubMed ID: 2328267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New designed HMBA agents as inducers of erythroleukemia cell differentiation.
    Wang H; Zhang S; Zhou J; Zhang J
    Chin Med Sci J; 2002 Mar; 17(1):27-31. PubMed ID: 12894881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hexamethylene bisacetamide inhibits malignant phenotype in T-ALL cell lines.
    Cecchinato V; Erba E; Basile A; Scarpati B; Fazi C; Brando B; Comi P; Chiaramonte R
    Leuk Res; 2008 May; 32(5):791-7. PubMed ID: 17964649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid receptors in murine erythroleukaemic cells.
    Hammond KD; Torrance JM; DiDomenico M
    J Recept Res; 1987; 7(5):667-78. PubMed ID: 3477641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S; Scher BM; Hellinger N; Scher W
    Cancer Res; 1990 Jul; 50(13):3878-87. PubMed ID: 2354439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous wild-type p53 gene improved survival of nude mice injected with murine erythroleukemia cell line through amelioration of hemorheological changes.
    Zhang Y; Yao W; Zeng Z; Wang X; Sun D; Ka W; Zhou S; He D; Wen Z; Chien S
    Microcirculation; 2007 Feb; 14(2):155-66. PubMed ID: 17365670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,6-Diaminohexane contributes to the hexamethylene bisacetamide-induced erythroid differentiation pathway by stimulating Ca2+ release from inositol 1,4,5-trisphosphate-sensitive stores and promoting Ca2+ influx.
    Rajagopalan V; Blankenship J; Thomas DW
    Arch Biochem Biophys; 2006 Jan; 445(1):129-37. PubMed ID: 16343414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the mechanism of action of hexamethylene bisacetamide, a potent inducer of erythroleukemic differentiation.
    Reuben RC
    Biochim Biophys Acta; 1979 Dec; 588(3):310-21. PubMed ID: 292456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
    Richon VM; Rifkind RA; Marks PA
    Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
    Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
    J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
    Yamashita T; Eto Y; Shibai H; Ogata E
    Cancer Res; 1990 Jun; 50(11):3182-5. PubMed ID: 2334914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic RAS genes impair erythroid differentiation of erythroleukaemia cells.
    Zaker F; Darley RL; al Sabah A; Burnett AK
    Leuk Res; 1997 Jul; 21(7):635-40. PubMed ID: 9301684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bis-pyrrolyl-tetrazolyl derivatives as hybrid polar compounds: A case of lipophilic functional bioisosterism with bis-acetamides.
    Chatzopoulou M; Bonovolias ID; Nicolaou I; Demopoulos VJ; Vizirianakis IS; Tsiftsoglou AS
    Eur J Med Chem; 2012 Apr; 50():75-80. PubMed ID: 22341896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Differentiating Agent Hexamethylene Bisacetamide Inhibits BET Bromodomain Proteins.
    Nilsson LM; Green LC; Muralidharan SV; Demir D; Welin M; Bhadury J; Logan DT; Walse B; Nilsson JA
    Cancer Res; 2016 Apr; 76(8):2376-83. PubMed ID: 26941288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A possible effect of heme on the fate of DNA ligase activity extracted from differentiating mouse erythroleukemia cells.
    Scher BM; Scher W; Waxman S
    Cancer Res; 1988 Nov; 48(22):6278-84. PubMed ID: 3180046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in CuZn-superoxide dismutase during induced differentiation of murine erythroleukemia cells.
    Paoletti F; Mocali A
    Cancer Res; 1988 Dec; 48(23):6674-7. PubMed ID: 3180077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.